{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Propranolol&page=2", "query": { "intervention": "Propranolol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Propranolol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-04T16:49:32.578Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02620579", "title": "Biopsychosocial Influence on Shoulder Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Shoulder Pain" ], "interventions": [ { "name": "Propranolol LA (60 mg)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Shoulder Anatomy Education", "type": "BEHAVIORAL" }, { "name": "Pain Processing Education", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 264, "start_date": "2016-01", "completion_date": "2021-11-05", "has_results": true, "last_update_posted_date": "2023-01-13", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02620579" }, { "nct_id": "NCT00748059", "title": "The Pathophysiology of Orthostatic Hypotension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autonomic Nervous System Diseases", "Orthostatic Hypotension", "Dopamine Beta-Hydroxylase Deficiency", "Orthostatic Intolerance" ], "interventions": [ { "name": "Standing or upright tilt", "type": "PROCEDURE" }, { "name": "Microneurography", "type": "PROCEDURE" }, { "name": "QSweat", "type": "PROCEDURE" }, { "name": "neck cuff stimulation", "type": "DEVICE" }, { "name": "phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine", "type": "DRUG" }, { "name": "clonidine,yohimbine,metoclopramide,alpha-methyldopa", "type": "DRUG" }, { "name": "BodPod", "type": "PROCEDURE" }, { "name": "Eye exam", "type": "PROCEDURE" }, { "name": "Sleep study", "type": "PROCEDURE" }, { "name": "Pain response testing", "type": "PROCEDURE" }, { "name": "Metabolic chamber", "type": "PROCEDURE" }, { "name": "Brain function studies", "type": "PROCEDURE" }, { "name": "Bicycle Exercise Test", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 10, "start_date": "1996-12", "completion_date": "2020-12", "has_results": false, "last_update_posted_date": "2021-05-12", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00748059" }, { "nct_id": "NCT02670161", "title": "Quality Improvement and Practice Based Research in Neurology Using the EMR", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Brain Tumors", "Epilepsy", "Migraine", "Mild Cognitive Impairment", "Concussion", "Multiple Sclerosis", "Neuropathy", "Parkinson's", "Restless Legs Syndrome", "Stroke" ], "interventions": [ { "name": "Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field; see Intervention Description)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endeavor Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 3300, "start_date": "2016-05", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2025-08-24", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "Evanston, Illinois", "locations": [ { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02670161" }, { "nct_id": "NCT01988883", "title": "Modafinil and Cognitive Function in POTS", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Postural Tachycardia Syndrome" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Propranolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 20, "start_date": "2014-10", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-15", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01988883" }, { "nct_id": "NCT03348683", "title": "Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Induction of Labor Affected Fetus / Newborn" ], "interventions": [ { "name": "Propranolol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 240, "start_date": "2017-12-11", "completion_date": "2018-12-11", "has_results": true, "last_update_posted_date": "2020-01-07", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03348683" }, { "nct_id": "NCT00262470", "title": "Treatment of Orthostatic Intolerance", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Tachycardia", "Chronic Orthostatic Intolerance" ], "interventions": [ { "name": "Acetazolamide", "type": "DRUG" }, { "name": "Atomoxetine", "type": "DRUG" }, { "name": "NO Drug", "type": "OTHER" }, { "name": "Clonidine", "type": "DRUG" }, { "name": "Entacapone", "type": "DRUG" }, { "name": "Entacapone & Propranolol", "type": "DRUG" }, { "name": "Atomoxetine & Propranolol", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Mecamylamine", "type": "DRUG" }, { "name": "Isosorbide Dinitrate", "type": "DRUG" }, { "name": "Melatonin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Midodrine", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Octreotide", "type": "DRUG" }, { "name": "Placebo", "type": "RADIATION" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Modafinil & Propranolol", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "IV Saline", "type": "PROCEDURE" }, { "name": "Drinking Water", "type": "OTHER" }, { "name": "Breathing Device", "type": "DEVICE" }, { "name": "memantine", "type": "DRUG" }, { "name": "Abdominal binder", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "RADIATION", "PROCEDURE", "DEVICE" ], "sponsor": "Satish R. Raj", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 150, "start_date": "1997-04", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2025-10-08", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00262470" }, { "nct_id": "NCT01978457", "title": "Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cocaine Dependent Subjects" ], "interventions": [ { "name": "cocaine hydrochloride", "type": "DRUG" }, { "name": "propranolol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 6, "start_date": "2012-10", "completion_date": "2019-12", "has_results": false, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01978457" }, { "nct_id": "NCT01056341", "title": "Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infantile Hemangioma" ], "interventions": [ { "name": "Propranolol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pierre Fabre Dermatology", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Days", "maximum_age": "150 Days", "sex": "ALL", "summary": "35 Days to 150 Days" }, "enrollment_count": 512, "start_date": "2010-01", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-12-10", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 10, "location_summary": "Irvine, California • Redwood City, California • San Diego, California + 7 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01056341" }, { "nct_id": "NCT00069355", "title": "Propranolol for the Treatment of Acute Stress Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stress Disorders, Traumatic, Acute" ], "interventions": [ { "name": "Propranolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Mental Health (NIMH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 50, "start_date": "2003-09", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00069355" }, { "nct_id": "NCT00608725", "title": "Pathophysiology of Orthostatic Intolerance", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tachycardia", "Postural Orthostatic Tachycardia Syndrome" ], "interventions": [ { "name": "DAXOR", "type": "RADIATION" }, { "name": "QSweat", "type": "PROCEDURE" }, { "name": "Intrinsic Heart Rate", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "PROCEDURE", "DRUG" ], "sponsor": "Satish R. Raj", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 260, "start_date": "1996-12", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2025-10-08", "last_synced_at": "2026-09-04T16:49:32.578Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00608725" } ] }